EP 0828508 A2 19980318 - COMPOSITIONS OF INTERLEUKIN AND PYRIMIDINE NUCLEOSIDES
Title (en)
COMPOSITIONS OF INTERLEUKIN AND PYRIMIDINE NUCLEOSIDES
Title (de)
INTERLEUKIN-HALTIGE ZUSAMMENSETZUNGEN UND PYRIMIDIN NUKLEOSIDE(06.02.97)
Title (fr)
COMPOSITIONS A BASE D'INTERLEUKINE ET DE NUCLEOSIDES DE PYRIMIDINE
Publication
Application
Priority
- EP 96917379 A 19960515
- EP 9602088 W 19960515
- EP 95108063 A 19950526
Abstract (en)
[origin: WO9637214A2] A synergistic antitumor pharmaceutical composition comprising an effective amount of interleukin-12 and a pyrimidine nucleoside derivative as well as a hydrate or solvate thereof that is converted into fluorouracil or its derivative, and a pharmaceutically acceptable carrier.
IPC 1-7
IPC 8 full level
A61K 31/70 (2006.01); A61K 31/7042 (2006.01); A61K 31/7052 (2006.01); A61K 31/7064 (2006.01); A61K 31/7068 (2006.01); A61K 31/7072 (2006.01); A61K 38/00 (2006.01); A61K 38/20 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07H 19/06 (2006.01)
CPC (source: EP)
A61K 38/208 (2013.01); A61P 35/00 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 9637214A2
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9637214 A2 19961128; WO 9637214 A3 19970109; AR 005417 A1 19990623; AU 5998296 A 19961211; BR 9608779 A 19990706; CA 2220837 A1 19961128; CN 1184430 A 19980610; EP 0828508 A2 19980318; JP H10506641 A 19980630; MX 9708915 A 19980331; TR 199701435 T1 19980321
DOCDB simple family (application)
EP 9602088 W 19960515; AR 10265296 A 19960522; AU 5998296 A 19960515; BR 9608779 A 19960515; CA 2220837 A 19960515; CN 96194016 A 19960515; EP 96917379 A 19960515; JP 53534296 A 19960515; MX 9708915 A 19960515; TR 9701435 T 19960515